During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

While the broader market showed resilience to global geopolitical and economic pressures in June, the ASX 200 Health Care ...

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.

Rare, deadly, and often missed, some skin cancers develop in areas that rarely see the sun. Scientists are still learning about them, but here's what we know.

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

At the moment, the only therapy available to patients with FOP – a disorder in which bony lesions are laid down in muscles, tendons, and ligaments – are drugs to treat symptoms including pain.

We present the case of a 48-year-old man with a background of well-controlled HIV who presented with bony pain in multiple regions and raised inflammatory markers. After an investigative process, the ...

Abstract: Skeletal metastasis has tendency to develop from any kind of primary tumor. In the spine, the vertebral body is the most common site of metastasis which then extends to pedicle. About 2/3 rd ...

A 59 year old woman presented with a three year history of left sided weakness. Magnetic resonance imaging of the brain showed a large high signal lesion occupying most of the right temporal lobe with ...

In many ways, it may be easier to highlight what rheumatoid arthritis (RA) and psoriatic arthritis (PsA) have in common. They are both common conditions characterised by a spectrum of features or ...